Clinical Trials on Neoplasms, Squamous Cell in South Africa
Total 6649 results
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
Provectus PharmaceuticalsCompleted
-
University of South CarolinaCompletedNon Small Cell Lung Cancer | Resistance ExerciseUnited States
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Lymphoma FollicularUnited States, Australia, Italy
-
Medical University of South CarolinaGlaxoSmithKline; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
SanofiGenzyme, a Sanofi CompanyCompletedProstate Cancer | Metastatic | Hormone RefractoryBrazil, South Africa, Sweden, Germany, Hungary
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Bristol-Myers SquibbActive, not recruiting
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerUnited States
-
Northern Sydney and Central Coast Area Health ServiceMerck KGaA, Darmstadt, GermanyUnknownNewly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4Australia
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungAustralia
-
Lpath, Inc.TerminatedRenal Cell CarcinomaUnited States
-
Hellenic Society of HematologyTakeda; Janssen Pharmaceutica NVUnknown
-
Hellenic Society of HematologyJanssen PharmaceuticalsUnknown
-
SanofiCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin LymphomaUnited States
-
Melanoma and Skin Cancer Trials LimitedTrans Tasman Radiation Oncology GroupActive, not recruiting
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
SCRI Development Innovations, LLCGlaxoSmithKline; OSI PharmaceuticalsCompletedNon Small Cell Lung CancerUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineActive, not recruiting
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
-
QBiotics Group LimitedTerminated
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
Novartis PharmaceuticalsTerminatedCarcinoma, Renal CellAustralia, Korea, Republic of
-
Medical University of South CarolinaTerminatedKidney CancerUnited States
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
PlexxikonTerminatedSolid Tumor | Tenosynovial Giant Cell Tumor | Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion MutationsUnited States
-
International Atomic Energy AgencyCompletedEsophageal CancerChina, Canada, Croatia, India, Pakistan, South Africa, Thailand
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditionsUnited States
-
Provectus PharmaceuticalsCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Hoosier Cancer Research NetworkEli Lilly and Company; Walther Cancer InstituteTerminatedLymphoma, B-CellUnited States
-
Medical University of South CarolinaTerminatedGlioma | Astrocytoma | Brain Tumor | Glioblastoma MultiformeUnited States
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
National Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, South Africa, Peru, Puerto Rico
-
Bristol-Myers SquibbCompletedRenal Cell CarcinomaUnited States, Australia, Chile
-
Biofrontera Bioscience GmbHActive, not recruitingSuperficial Basal Cell CarcinomaUnited States
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedKaposi's Sarcoma | HIV-1 InfectionPeru, Kenya, Malawi, Brazil, South Africa, Uganda
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | ATR Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CHEK1 Gene Mutation | FANCA Gene... and other conditionsUnited States, Canada
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Metastases, NeoplasmUnited States
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedNon Small Cell Lung CancerAustralia, New Zealand, Spain
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States, Australia, Puerto Rico, South Africa
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedNon-Small-Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsCompletedSickle Cell AnemiaTurkey, United States, Germany, Canada, United Kingdom, Israel, South Africa
-
Melanoma and Skin Cancer Trials LimitedUniversity of Oxford; Trans Tasman Radiation Oncology GroupActive, not recruitingMetastatic MelanomaNorway, Australia, United Kingdom
-
AstraZenecaCompletedCarcinoma, Renal CellUnited States